期刊文献+

胃癌组织中RUNX3的表达与c-Met的相关性研究 被引量:2

A study of the correlation between RUNX3 expression and c-Met in gastric carcinoma tissue
下载PDF
导出
摘要 目的:探讨RUNX3及c-Met在胃癌组织中的表达以及与胃癌临床病理特征之间的关系。方法:以56例胃癌患者为研究对象,采用SP免疫组化法研究RUNX3及c-Met在正常胃黏膜及不同分期,不同分化程度各组胃癌标本中的表达。结果:胃癌组织中RUNX3的表达明显降低,c-Met的表达显著提高。RUNX3、远隔转移、临床分期呈正相关,与肿瘤分化程度、肿瘤大小、患者性别、年龄无相关性。RUNX3与c-Met的表的表达与胃癌浸润深度、远隔转移、临床分期呈负相关(P<0.05),与胃癌病理分化程度呈正相关,与胃癌病灶大小,淋巴结有无转移,患者性别,年龄无相关性。c-Met的阳性表达率与胃癌的浸润深度、淋巴转移达有相关性(P<0.05)。结论:胃癌组织中RUNX3表达下调,提示其在胃癌发生,发展中起重要作用,c-Met的表达与RUNX3表达的存在相关性。 Objective:To investigate the expression and clinical significance of RUNX3 and c - Met in gastric cancer. Methods : Immuno - histochemistry stain was used to determine the expression of RUNX3 and c - Met in different differentiated cancerous tissue in 56 patients. Results:RUNX3 had low expression rate in gastric cancer, c - Met had a high expression rate in gastric cancer. The depression of RUNX3 was related to the depth of invasion, metastasis, TNM stage (P 〈 0.05 ). The depression of RUNX3 had no relationship with differentiate type, the size of lesion, lymph - metastasis, gender and age of patient. Expression of c - Met was related to the depth of invasion, lymph - metastasis, metastasis, TNM stage ( P 〈 0.05 ) and not related to differentiate type, size of lesion, gender and age of patient. The correlation between RUNX3 and c - Met was significant ( r = - 0.262, P 〈 0.05 ). Conclusion:The depression of RUNX3 in gastric cancerous tissue suggests that RUNX3 plays an important role in gastric cancer development and progression. RUNX3 down - regulate the expression of c - Met.
出处 《现代肿瘤医学》 CAS 2011年第1期85-88,共4页 Journal of Modern Oncology
基金 辽宁省高等学校科研项目(编号:2008S226) 沈阳市科学技术计划项目(编号:080411)
关键词 RUNX3 c—Met 胃癌 RUNX3 : c - Met : castric carcinoma
  • 相关文献

参考文献16

  • 1Waki T,Tamura G,Sato M,et al.Promoter methylation status of DAP2 kinase and Runx3 genes in neoplastic and non-neoplastic gastric epithelia[J].Cancer Sci,2003,94:360-364.
  • 2Kim TY,Lee HJ,Hwang KS,et al.Methylation of Runx3 in various types of human cancers and premalignant stages of gatric carcinoma[J].Lab Invest,2004,84:479-484.
  • 3Osaki M,Moriyama M,Adachi K,et al.Expression of Runx3 protein in human gastric mucosa,intestinal metaplasia and carcinoma[J].Eur J Chin Invest,2004,34:605-612.
  • 4Levanon D,Negreanu V,Bernstein Y,et al.AML1,AML2,and AML3,the human members of the runt domain gene-family:cDNA structure,expression,and chromosomal localization[J].Genomics.1994,23(2):425-432.
  • 5Wei D,Gong W,Oh SC,et al.Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis[J].Cancer Red,2005,65(11):4809-4816.
  • 6Li QL,Ito K,Sakakura C,et al.Causal relationship between the loss of Runx3 expression and gastric cancer[J].Cell,2002,109:113-124.
  • 7陈榆,吴开春.抑癌基因降低胃癌转移的新通路通过增强游靶基因TIMP-1的转录表达从而抑制MMPg的酶活性[J].中华医学会第七次全国消化病学术会议论文汇编(下册):1326-1327.
  • 8Chouhei Sakakura,Kazunori Hasegawa,Koji Miyagawa,et al.Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers[J].Clin Cancer Res,2005,11:6479-6488.
  • 9Qian CN,Guo X,Cao B,et al.Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma[J].Cancer Res,2002,589-596.
  • 10Bottaro DP,Rubin JS,Faletto DL,et al.Identification of the hepatocyte growth factor receptor as the c-Met proto-oncogene product[J].Science,1991,251(4995):802-804.

同被引文献23

  • 1曾超,贺修胜,罗桥,赵帅,邓敏.胃癌中RUNX3蛋白表达与胃癌关系的研究[J].癌变.畸变.突变,2006,18(6):455-458. 被引量:3
  • 2Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin, 2005, 55(2): 74-108.
  • 3Bangsow C, Rubins N, Glusman G, et al. TheRUNX3 gene-sequence, structure and regulated expression. Gene, 2001, 279(2): 221-232.
  • 4Li QL, Ito K, Sakakura C, et al. Causal relationship betweenthe loss of RUNX3 expression and gastric cancer. Cell, 2002, 109(1): 113-124.
  • 5Lau QC, Raja E, Salto-tellez M, et al. RUNX3 is frequently inacti- vated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res, 2006, 66(13): 6512- 6520.
  • 6Takahashi T, Shivapurkar N, Riquelme E, et al. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis. Clin Cancer Res, 2004, 10(18 Pt1): 6126-6133.
  • 7Bae SC, Choi IK. Tumor suppressor activity of RUNX3. Oncogene, 2004, 23(24): 4336-4340.
  • 8Wells G A, Shea B, O'connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 3rd Symposium on Systematic Reviews: Beyond the Basics. 2000.
  • 9Stang A. Critical evaluation of the Newcastle-Ottawa scale for the as- sessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology, 2010, 25(9): 603-605.
  • 10Taniuchi I, Osato M, Egawa T, et al. Differential requirements for Runx proteins in CD4 repressionand epigenetic silencing during T lymphocyte development. Cell, 2002, 111(5): 621-633.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部